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ABSTRACT 
 
 Wound healing is a process of naturally regenerating epidermal and dermal tissue to 
repair damage.  Wound healing is a highly developed biological defense mechanism that 
prevents bodily fluid leakage, provides protection for a regenerating cellular barrier, and allows 
for removal of tissue residues and foreign materials.  The goal of the laboratory is to develop 
methods for de-differentiation of adult fibroblasts back into a pluripotent state and to promote a 
regenerative response instead of scar formation. 
 It is well known that human bone marrow contains a population of cells that are capable 
of differentiating along different mesenchymal cells lineages when cultured under the 
appropriate conditions.  We analyzed the ability of bone marrow-derived stem cells (hMSC-
BM1), umbilical cord blood-derived stem cells (hMSC-SC00125), quiescent (SS-2352), and 
FGF-2 (2352) stimulated adult human dermal fibroblasts to differentiate into the three main 
lineages:  chondrogenic, osteogenic, and adipogenic.  Histochemical and immunocytochemistry 
assays were performed on the cell cultures to determine the success of specific differentiation 
protocols.  All treatments but the umbilical cord blood-derived stem cells differentiated into the 
adipogenic lineage.  None of the treatments successfully differentiated into the chondrogenic or 
osteogenic lineages even though the bone marrow-derived stem cells had some alizarin red and 
toluidine blue staining.  The purpose of this project was to develop in vitro assays with which to 
measure success of future de-differentiation experiments.   
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BACKGROUND 
 
Wound Healing and Repair 
 Most mammals including humans show poor regenerative ability following severe 
trauma.  The regeneration of truncated or partial limbs does not occur in normal development.  In 
contrast, urodele amphibians (e.g. salamanders) are capable of regenerating a variety of organs 
and bodily structures.  Limb regeneration represents an elaborate process in which wound 
healing, cellular de-differentiation, tissue remodeling, and patterning occur to replace the 
amputated limb.  Understanding urodele limb regeneration could lead to the identification of the 
key components required for regeneration in humans.  Previous research has demonstrated that 
with the correct cues adult tissue may be directed along an alternate pathway of wound repair.  
This example suggests that higher order vertebrate limb regeneration may be possible (Muller et 
al, 1999).   
 Human skin is made up of three layers of tissue known as the epidermis, dermis, and 
subcutis.  The epidermis is the protective outer most layers mainly composed of dead squamous 
cells.  The cells beneath the superficial layer include dense granules of cytoplasm made up of 
basal cells.  The dermis, which is located beneath the epidermis consists of two layers, the 
papillary and reticular.  The papillary layer contains layers of collagen fibers which are 
interwoven with elastic fibers whose primarily role is thermoregulation.  The reticular layer 
provides the structural component of skin and is composed of collagen, elastin, and reticular 
fibers.  The innermost layer, subcutis, otherwise known as hypodermis, is made up of a thick 
layer of adipose tissue that separates the skin from the underlying muscle mass, which maintains 
the structure of skin appendages such as hair follicles and sweat glands in nonfurred animals 
 6 
(Skin Biology, 2008).  Our skin provides a barrier from pathogens and trauma from our external 
environment and helps maintain the homeostasis of our bodily fluids, electrolytes, and 
temperature.  
 A wound is described as a traumatic disruption of any bodily tissue and is categorized by 
its gross appearance.  Wound healing and repair is a process of naturally regenerating epidermal 
and dermal tissue to repair the damage.  Wound healing is a highly developed biological defense 
mechanism which prevents bodily fluid leakage, provides protection for a regenerating cellular 
barrier, and allows for removal of tissue residues and foreign materials (Jeong et al, 2008).  
These processes overlap in time and are categorized by three phases, inflammatory, proliferative, 
and maturation phases.  
 The inflammation phase of wound healing occurs immediately after the injury.  Potent 
vasoconstrictors are released to minimize blood vessel diameter, which prevents hemorrhaging.  
After the bleeding has ceased, capillary vasodilatation occurs and the cells of inflammation are 
able to migrate to the wound site.  The exposed collagen activates a blood-clotting cascade.  
Platelets, one of the formed elements of blood, are responsible for initiating the formation of a 
blood clot.  These activated platelets release multiple chemokines including epidermal growth 
factor (EGF), histamine, platelet-derived growth factor (PDGF), serotonin, and tissue factor that 
act to stabilize the wound.  Neutrophils fight infection by migrating to the wound site to remove 
bacteria and foreign debris.  As the process continues, macrophages secrete copious amounts of 
enzymes and cytokines.  These include collagenases, which aid in debridement of the wound; 
interleukins and tumor necrosis factor (TNF) that stimulate fibroblasts to produce collagen and 
promote angiogenesis; and transforming growth factor (TGF) that stimulates keratinocytes to 
synthesize keratin (Rosenberg et al, 2006).   
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 In the proliferative phase, several steps occur that include epithelialization, angiogenesis, 
granulation tissue formation, and collagen deposition.  During epithelialization, if the basement 
membrane remains intact, epithelial cells migrate toward the wound and form layers over the 
denuded surface.  If these newly formed layers remain intact, the epidermis can be restored 
within 2-3 days.  Angiogenesis, the development of blood vessels referred to as 
neovascularization in developing fetuses or revascularization anytime after birth by endothelial 
cells, is stimulated by TNF-α.  The newly formed capillaries provide nutrients to the wound and 
aid in tissue formation.  Granulation tissue formation is the final part of the proliferative phase.  
Fibroblasts differentiate and produce ground substance (extracellular proteoglycans) and 
collagen.  The ground substance is deposited into the wound bed; collagen is then deposited as 
the wound undergoes the final phase of repair.  Numerous cytokines are involved is this phase of 
wound healing including PDGF, insulin-like growth factor (IGF), and EGF.  These cytokines are 
involved in collagen production (Rosenberg et al, 2006).  
 The final phase in wound healing is maturation.  New collagen continues to form, which 
increases the tensile strength.  New blood vessels establish circulation in the healing area, 
fibroblasts leave the wound and collagen is remodeled into a more organized matrix.  Tensile 
strength reaches its maximum after about a year leaving only a small volume of scar tissue 
(Gilmore, 1991).  
 In humans, severe damage to bodily tissues pose problems such as the degree of scarring 
and the inability to successfully heal and/or regenerate lost tissue and bodily structures.  
Urodeles have a more rapid response and are capable of complete scarless regeneration of lost 
bodily organs and structures.  Immediately following amputation, epidermal cells from the 
perimeter of the limb migrate without cell division to cover the wound surface.  This phase of the 
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healing process is completed in approximately 12 hours after amputation.  In the following days, 
the thin layer of epithelial cells thickens into the multilayered wound epithelium.  This is 
accompanied by histolysis of stump tissues such as bone and muscle (Campbell, 2008).   
 The tissue interaction that is perhaps most critical for regeneration and which is unique to 
urodeles among adult amphibians is blastema formation, a necessary response for a successful 
regeneration.  The blastema is composed of a large zone of progenitor cells that migrate and 
form a simple secretory epidermis.  Studies have established that de-differentiation of fibroblasts 
is the major cellular mechanism that leads to formation of the blastema.  The blastema is 
responsible for forming the underlying muscles, cartilage, bone, dermis, and Schwann cells.  De-
differentiation is a multistep process where a cell reenters the cell cycle and loses its 
differentiated qualities (Tanka, 2003).  The resulting blastema cells express several markers that 
are not expressed by differentiated mesenchymal cells of the normal limb or by cells of the 
developing limb bud.   
 Studies have shown that the homeobox transcription factor Msx-2 has been detected in 
the apical dermis of the regenerating limb.  Its expression level is relatively low in uninjured 
limb tissues, and has been detected in the epidermis at higher levels as early as one hour after 
amputation (Campbell, 2008).  Fibroblast growth factor-2 (FGF-2) has also been implicated in 
limb bud induction in vertebrate development and is mitogenic for a variety of cell types.  FGF-2 
has been shown necessary to keep human embryonic stem (ES) cells from spontaneously 
differentiating in culture without feeder cells, though its role in differentiation is unknown.  
Components needed to induce pluripotency were recently narrowed down to two core 
transcription factors, Oct-4 and Sox-2 with increased efficiency provided by Nanog and Lin-28.  
Oct-4 and Sox-2 function to determine pluripotency by simultaneously upregulating genes, while 
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suppressing differentiation-associated genes in both mouse and human ES cells.  Other inhibitory 
mechanisms including DNA methylation and histone modifications inhibit binding of target 
genes in differentiated cells (Takahashi et al, 2007).   
 
Stem Cells 
 Stem Cells are unspecialized cells and can renew themselves for extended periods of 
time.  More importantly, what makes them useful to regenerative medicine is the fact that they 
can differentiate into other mature cell types.  Stem cells can be divided into two different 
categories, adult stems cells and embryonic stem (ES) cells.  The characteristics and properties of 
these two groups differ in their potential to differentiate.  ES cells are pluripotent in that they are 
capable of differentiating into any cell type in the body (except the placenta).  Adult stem cells 
are multipotent cells that are only able to differentiate into a limited number of cell types.  Adult 
stem cells are rare, difficult to isolate and maintain in culture, and are not perpetually self-
renewing like ES cells (Satija et al, 2007).  Conducting experiments involving embryonic stem 
cells is challenging as there are many political and ethical issues surrounding the use of these 
particular cells for scientific purposes.  The use of adult stem cells presents fewer challenges, and 
offers the potential to treat a patient with cells derived from their own bodies.  The use of these 
cells also alleviates the medical complications associated with immune system rejection in 
allograft cell/tissue therapy.    
 A common misconception with regard to stem cells is that they are all alike.  Two 
different populations of stems cells can be isolated from bone marrow, Hematopoietic Stem Cells 
(HSCs) and Mesenchymal Stem Cells (MSCs).  Even though both HSCs and MSCs are isolated 
from bone marrow they exhibit different characteristics and properties.  HSCs are nonadherent 
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cells whose main function is to replenish blood cells.  These cells have been used for over forty 
years in the form of bone marrow transplants, to successfully treat individuals with cancer, and 
blood and immune system disorders (Abbott, 2003).  Conversely, MSCs are adherent cells whose 
main function is to repair the structural components of the bone such as cartilage, bone matrix, 
and fat.  The circulating MSCs are implicated in stimulating the tissue repair process, but have 
not been shown to play a role in the formation of new tissue apart from the bone.  MSCs are the 
easiest to isolate, are multipotent, and display maximal proliferation among adult stem cells.   
 
Embryonic and Mesenchymal Stem Cells   
 ES cells are unspecialized and non-tissue specific.  Approximately five to seven days 
after fertilization the embryo is a blastocyst that looks like a hollow ball and is composed of the 
inner cell mass (ICM) surrounded by a layer of differentiated cells called the trophoblast 
(Embryonic Stem Cells, 2006).  ES cells are derived from the ICM of the blastocyst and have the 
unlimited potential to differentiate into any cell type in the body (except the placenta) if provided 
the correct physical and chemical environmental stimulus.  Research on embryonic stem cells is 
still in its infancy due to the fact that they were first isolated in humans in 1998.  One problem 
when using embryonic stem cells is their potential toward immune system rejection in allograft 
cell/tissue therapy applications.  Adult stem cell research has been ongoing since the 1960s, and 
these cells provide researchers with the ability to obtain autologous tissue for implantation 
(ISSCR, 2004).  Although to date no human ES clinical trials have been completed some success 
has been obtained with animal disease models and ES cells.  ES cells are capable of long-term 
self-renewal and are thought to have the most medical potential in tissue engineering 
applications due to their pluripotency.      
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 MSCs are adherent populations of fibroblast-like cells that were first isolated from bone 
marrow more than thirty years ago.  Their multipotency has made them a popular target for use 
in tissue engineering applications.  However, the ability to mimic the in vivo environment 
towards synthesizing tissue in vitro remains a challenge.  Host versus graft disease in 
nonautologous applications, efficient induction of desired differentiation pathways, and 
availability of large populations of cells are obstacles that need to be overcome (Satija et al, 
2007).     
 Extensive reports indicate that among different lineages, MSCs derived from bone 
marrow show the ability to differentiate into chondrocytes, adipocytes, and osteocytes.  It is 
noted that single-celled-derived colonies are morphologically heterogeneous such that they 
contain both small, rapid self-renewing cells and large, slowly replicating cells (Prockop et al, 
2003).  The small, rapid self-renewing cells (RS cells) remain rich in culture for four to five 
passages if maintained at a low cell density.  If allowed to reach confluence, large mature cells 
that cease to proliferate will dominate the cultures.  RS cells exhibit a greater potential to 
differentiate into multiple lineages than the larger mature cells.  However, confluent cultures of 
large slow replicating cells continue to secrete a variety of growth factors that has been shown to 
serve as a good feeder layer for HSCs (Prockop et al, 2003).  
 
Applications and Therapeutic Approaches 
 Amputation is a permanent disfigurement that provides relief from pain or disease in the 
affected limb and may be welcomed by the amputee, or produce feelings of resentment for those 
losing a sound limb.  Prosthetics is the design, fabrication, and fitting of artificial limbs or other 
assistive devices for patients who have congenital defects or have lost limbs as a result of 
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traumatic injuries or diseases (e.g. diabetes).  For almost thirty years, prosthetic clinicians and 
researchers worldwide have designed materials that have greatly improved the connection 
between the socket and limb remnant (stump).  The most critical aspect of any prosthesis is the 
quality of the interface between the stump and the artificial prosthesis.  The portion of the 
prosthesis that fits snugly over the limb remnant (the socket) determines the amputee’s comfort, 
ability to control the artificial limb, and is critical for maximum healing and minimum pain 
(Marks et al, 2001).  
 The tissue damage that causes joint destruction results from inflammation that is caused 
by an injury, or degenerative rheumatic diseases such as arthritis.  Articular cartilage is primarily 
composed of chondrocytes and is critical in the movement of bones, which provide mechanical 
support to the limbs.  Chondrocytes consumption of oxygen decreases with age, which causes 
over-matured cells to lose their ability to aid in repair.  Current therapeutic approaches are aimed 
at removing damaged tissue, reducing the rate of further damage, and prescribing medication to 
paliate pain.  These approaches cannot correct for major functional losses due to traumatic loss 
of tissue.   
 Scientists who work to repair damaged tissue have tried to recreate the correct 
microenvironment necessary for tissue repair.  Genzyme has developed a product called 
Carticel that consists of cultured autologous chondrocytes implantation.  Carticel is used to 
treat patients who have clinically significant articular cartilage lesions of the knee caused by 
trauma that has not responded to prior therapy.  Carticel therapy is a much less invasive surgical 
procedure than total knee replacement and removes very little of the patient’s natural knee joint.  
The implantation usually only lasts about 10 to 15 years and is generally considered a poor 
alternative for patients less than 50 years of age (Genzyme Receives…, 2007).  
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Chondrocytes, Osteocytes, and Adipocytes 
 Chondrocytes whose primary function is to produce and maintain the cartilaginous 
matrix, are the only cells found in cartilage.  The most commonly known form of cartilage is 
articular cartilage, which is a semi-translucent matrix located on the surface of joints.  Articular 
cartilage provides mechanical support to the limbs and cushions the joints between bones.  Injury 
to articular cartilage caused by trauma, overuse, and age-related degenerative diseases associated 
with joint destruction continue to remain a worldwide medical problem.   
 When grown in a monolayer after serial passages, chondrocytes lose their phenotypic 
traits, as measured by expression of salient markers such as collagen type II (Harrison et al, 
1991).  Extracellular matrix (ECM) also plays a physiological role by influencing the 
microenvironment of chondrocytes embedded within it.  Micromass cultures are utilized in 
attempts to replicate the microenvironment necessary for chondrogenesis (De Bari et al, 2001).   
 To promote chondrogenic differentiation a well-defined medium is imperative that should 
be devoid of animal products.  Serum contains uncharacterized growth and differentiation factors 
that may inhibit chondrogenesis.  Maintaining adherent cells in serum-free conditions presents 
major challenges in that it lowers the mitotic index, cells become apoptotic, and cells exhibit 
poor adhesion to tissue culture plates.  Completely serum-free conditions are shown to be 
detrimental to promotion of chondrogenic differentiation from MSCs (Heng et al, 2007).  
Synthetic serum substitutes, containing proteins such as HAS, trace elements, and amino acids 
(e.g. TCH) can be used in place of serum.  Research has identified numerous cytokines and 
growth factors important to chondrogenesis.  The recombinant human transforming growth 
factor (TGF-β) family, specifically TGF-β3, is one of the most potent inducers of chondrogenic 
differentiation (Heng et al, 2007).  TGF-β3 induces expression of chondrogenic maker, collagen 
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type II, when added to thermo-reversible hydrogel constructs but not in monolayer cultures (Na 
et al, 2006).  Other nonproteinaceous compounds that are known to promote chondrogenic 
differentiation are glucocorticoids (e.g. dexamethasone) and the prolyl hydroxylase cofactor 
ascorbic acid (vitamin C), which is required for collagen synthesis and secretion.  The addition 
of ascorbic acid is known to promote 1,25 dihydroxy vitamin D3 synthesis, and cartilage matrix 
production (Heng et al, 2007), whereas dexamethasone maintains the integrity of the 
cartilaginous matrix by expressing specific cartilage genes such as collagen type II (Na et al, 
2006).   
 Osteocytes are derived from osteoblasts, or other bone forming cells (MSCs) and are 
mature nondividing cells located within their own lacunae.  Osteocytes are essential for the 
maintenance and routine turnover of bone matrix.  Nutrients from blood vessels diffuse through 
the bone matrix to osteocytes through both the canaliculi that surround the cell, and gap 
junctions.  Diffusion of such nutrients is limited; therefore osteocytes cannot subsist at distances 
more than 0.2 mm from a given blood vessel (Cell, 2007).  The presence or absence of 
mechanical stimuli can initiate alterations of bone structure and mass.  Both osteoblasts and 
osteocytes express osteocalcein, the bone-specific marker. 
 Lineage specific inducing agents that contribute to osteogenic differentiation are 
necessary for in vitro culture conditions.  As mentioned previously, serum contains 
uncharacterized growth and differentiation factors that may result in spontaneous differentiation, 
although variations between different lots of serum have proven to influence mineralization 
(Jaiswal et al, 1997).  Growth factors such as FGF-2 stimulate proliferation of osteogenic 
precursors and enrich the expanded populations that are competent for osteogenic differentiation 
(Maegawa et al, 2007).  The glucocorticoid, dexamethasone (dex) is necessary for nodule 
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formation and mineralization despite the fact that dexamethasone also has shown both 
stimulatory and inhibitory effects on osteogenic differentiation depending on concentration, 
duration of exposure stage of differentiation, and species of responding cells (Jaiswal et al, 
1997).  As in chondrogenesis, ascorbic acid functions as a cofactor in hydroxylation of proline 
and lysine residues in collagen, increases synthesis of non-collagenous bone matrix proteins, and 
is considered essential for bone formation (Jaiswal et al, 1997).     
 Adipocytes are known to be responsible for storing excess fats and converting them into 
energy when needed.  Adipocytes are widely distributed throughout the body and are located 
within adipose tissue underneath the skin.  Adipocytes arise from the dietary intake of fat or 
carbohydrates in excess of that required.  There are two different types of adipose tissue, white 
and brown.  White adipose tissue (WAT) is the fat storage tissue whereas the brown adipose 
tissue (BAT) is known for its production of heat.  BAT, more commonly known as “baby fat”, is 
converted to WAT during adulthood.  The conversion from BAT to WAT is completed by 
mitochondrial uncoupling protein 1 (UPC-1).  UPC-1 is activated by the diet in the mitochondria 
and in some individuals ceases to function and often results in obesity (The Adipocyte…, 2006).   
 Obesity presents a significant clinical problem that contributes to life-threatening diseases 
like diabetes.  Adipogenesis, the formation of adipose tissue, is better understood by studying 
several cell types that can be induced to differentiate into adipocytes.  When treated with a 
combination of dexamethasone, 3-isobutyl-1-methylxanthine (IBMX), indomethacin, and 
insulin, the cells adopt a rounded phenotype and begin to accumulate lipids intracellularly in the 
form of lipid droplets.   Indomethacin is a ligand known for the peroxisome proliferator activator 
receptor gamma (PPAR-γ), a well-recognized early transcription factor in adipogenesis (Gregory 
et al, 2005).  IBMX is a phosphodiester inhibitor that blocks the conversion of cAMP to 5’ AMP 
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that results in the up-regulation of protein kinase A that is shown to be useful for adipogenic 
differentiation (Gregory et al, 2005). 
 
Fibroblasts 
 Fibroblasts are the principal cells of the connective tissue.  They are adherent, spindle-
shaped cells with processes that protrude from the ends of the cell body.  Fibroblasts from the 
lungs, cardiac system, and connective tissues are responsible for the production of extracellular 
matrix proteins that provide structural and functional integrity tissues throughout the body.  They 
also secrete various amounts of soluble factors including TGF-β, FGF, PDGF, and EGF.  These 
factors regulate a variety of cellular functions that include; DNA synthesis, protein secretion, cell 
migration, differentiation, and wound healing (Wang et al, 2006).  Fibroblasts are a 
heterogeneous group of cells that are easy to isolate and plentiful in the body.  Their response to 
mechanical loads, secretion of proteins into the extracellular matrix, and change in gene 
expression depends on the species, tissue type, and anatomical location (Grazul-Bilska et al, 
2003). 
 Meissner et al. have demonstrated that cell populations with properties similar to those of 
embryonic stem cells can be created from reprogrammed fibroblasts.  The reprogrammed 
fibroblasts are transformed back into a pluripotent state by genetically manipulating mature skin 
cells isolated from mice.  This was accomplished by introducing constitutively expressed 
transgenes encoding four transcription factors into the fibroblasts.  These genes include Oct-4, 
Sox-2, c-Myc, and Klf-4.  Both Oct-4 and Sox-2 are only normally active during early 
embryogenesis and are inactivated once development proceeds beyond the blastocyst stage.  
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 The reprogrammed cells were subjected to three different types of tests.  First, 
fluorescently labeled reprogrammed cells were injected into early-stage embryos and implanted 
into surrogate mothers to produce chimeric mice.  Offspring by outbreeding these chimeric mice 
contained labeled cells demonstrating that the reprogrammed cells contributed to the germ-line.  
Lastly, the reprogrammed cells were injected into genetically abnormal embryos, which can only 
form a placenta and not fetus.  These embryos were implanted and late gestation live fetuses 
were recovered (Meissner et al, 2007).  These results demonstrated that cell populations with 
properties similar to those of embryonic stem cells could be created from reprogramming 
fibroblasts.  Reprogrammed fibroblasts could become a useful tool in regenerative medicine for 
exploration and development of tissue-engineering applications to restore function to tissue lost 
to trauma or disease. 
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PROJECT PURPOSE 
 
 As mentioned earlier, stem cells are unspecialized cells that can renew themselves for 
extended periods of time and can be induced to form a variety of differentiated cells which 
makes them useful in regenerative medicine.  Mesenchymal stem cells’ multipotent capability 
has led to their popular use in tissue engineering research.  Even though MSCs are the relatively 
easy to isolate from a bone marrow aspiration, they are not copious within the body, and upon 
culture to large numbers, they lose their multipotentiality.  Fibroblasts are abundant and easily 
isolated and have a similar morphology to mesenchymal stem cells.  However, not much is 
known about the multipotent capability of human dermal fibroblasts.  The purpose of this project 
was to compare umbilical cord blood-derived stem cells, quiescent and FGF-2 stimulated adult 
human dermal fibroblasts to bone marrow-derived stem cells in their response to chondrogenic, 
osteogenic, and adipogenic in vitro differentiation protocols.  Histochemical staining and 
immunocytochemistry assays were performed on the cell cultures to determine the success of 
specific differentiation protocols. The goal of this project was to develop in vitro assays with 
which to measure success of future de-differentiation experiments.  
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MATERIALS AND METHODS 
 
Cell Expansion and Cryopreservation  
 For expansion, cells were plated at 0.5 ×106 cells per a T75 culture flask (BD Falcon), 
and cultured in monolayer in growth medium containing, 45% Dulbecco’s modified Eagle’s 
medium (DMEM; Mediatech) supplemented with 4mM of L-Glutamine (L-Gln; Mediatech), 
45% Ham’s F12 medium (F12; Mediatech), 10% FetalClone III (FC III; HyClone), and 4 ng/mL 
Fibroblast Growth Factor-2 (FGF-2; Chemicon) at 37°C in humidified atmosphere of 5% CO2, 
5% O2, and 90% N2.  The growth medium was replaced twice weekly until cells became near 
confluent.   
 Upon confluence, cells were washed with calcium and magnesium-free Dulbecco's 
Phosphate-Buffered Saline (DPBS−; Cellgro), detached with a 1:5 dilution of 0.25% trypsin 
containing 2.21 mM EDTA (trypsin-EDTA; Cellgro), and replated at 0.5 ×106 cells per T75 
culture flask in growth medium, or cryopreserved at 0.5 ×106 – 1.0 × 106 cells/mL in liquid 
nitrogen in medium that contained 1:1 ratio of DMEM with 4 mM L-Gln:F12, 10% FC III, and 
10% Dimethyl Sulfoxide (DMSO; Mediatech).  Cryopreserved cells were thawed at variable 
times (range 1-4 months) and replated for the in vitro differentiation induction.  
 Human bone marrow-derived MSCs (hMSC- BM1) were obtained from Lonza.  Human 
umbilical cord blood-derived MSCs (hMSC-SC00125) were obtained from Coriell Institute for 
Medical Research.  Human skin-derived fibroblasts (2352) were obtained from ATCC: The 
Global Bioresource Center.  hMSC- BM1, hMSC-SC00125, and 2352 cells were used for the 
Chondrogenic, Osteogenic, and Adipogenic differentiation assays.   
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Chondrogenic, Osteogenic, and Adipogenic Differentiation Assays   
 The potential for hMSC-BM1, hMSC-SC00125, SS-2352, and 2352 cells to differentiate 
into chondrogenic, osteogenic, and adipogenic lineages was assayed.  hMSC- BM1, hMSC-
SC00125, and 2352 cells were thawed and plated at 0.5 ×106 cells per a T75 culture flask, and 
cultured in monolayer in growth medium until approximately 80% confluence.  At 
approximately 80% confluence, half of the 2352 cells were serum starved, media was changed to 
a basal medium containing a 1:1 ratio of DMEM L-Gln:F12, and 2% FC III for two days.  After 
48 hours, the medium was replaced with a serum-free basal medium for four days.  This 
treatment was used for the SS-2352 cells.  The cells were harvested using trypsin-EDTA, and 
seeded to a 24-well culture plate (Greiner bio-one) for control, adipogenic, osteogenic, and 
chondrogenic treatments. 
 
In Vitro Chondrogenesis  
 For Chondrogenic differentiation, a modified technique described by De Bari et al. was 
used.  Micromass cultures were obtained by pipetting 20 µL droplets of cell suspension 
containing 0.5 ×106 cells per well into six wells of a 24 well plate.  The cells were allowed to 
adhere without medium for three hours at 37°C in humidified atmosphere of 5% CO2, 5% O2, 
and 90% N2, before adding 1 mL of growth medium.  This was designated as day 0.  Starting at 
day 1, the media was changed to a chemically defined chondrogenic differentiation medium 
consisting a 1:1 ratio of DMEM L-Gln:F12, 1X Insulin-Transferrin-Selium-X (ITS-X; 
Invitrogen), 1X TCH (Protide Pharmaceuticals, Inc.), 1 ng/mL transforming growth factor β3 
(TGF-β3; R&D Systems), 0.1 µM dexamethasone (dex; EMD), and 0.05 mM ascorbic acid 2-
phosphate (AsAP; Sigma) for forty days with a medium change twice per week.  Controls for 
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chondrogenic treatment were cultured in growth medium.  Cells were then washed twice with 
calcium and magnesium-free phosphate buffered-saline (PBS−; Cellgro), fixed with 3.7% 
formaldehyde for 15 minutes, and washed twice with PBS− for 5 minutes each. 
 For histochemical staining, cell pellets were rinsed in distilled water and stained with 
toluidine blue O (MP biomedical) using a modified technique described by De Bari et al. to 
evaluate proteoglycan content.  For immunocytochemical (ICC) analysis, cells were washed 
twice with PBS− for 5 minutes each, then incubated with 5 µg/mL of mouse monoclonal to type 
II collagen (abcam) in PBS− with 0.05% Tween 20 (PBS-Tween) for 30 minutes.  Cells were 
washed three times with PBS-Tween for 5 minutes each and further incubated with 4 µg/mL of 
goat anti-mouse IgG Alexa 488 (Invitrogen) in PBS-Tween for 30 minutes.  Cell pellets were 
then washed twice with PBS− for 5 minutes each.  All histochemical and ICC incubations were 
completed at room temperature. 
       
In Vitro Osteogenesis 
 For Osteogenic differentiation, a modified technique described by Maegawa et al. was 
used.  Cells were seeded at 0.1 × 106 cells per well into six wells of a 24 well plate and cultured 
to confluence; this was designated as day 0.  Starting at day 1, the cells were stimulated with 
medium containing a 1:1 ratio of DMEM L-Gln:F12, 10% FC III, 0.1 µM dex, 10 mM β-
Glycerophosphate (MP Biomedical), 0.05 mM AsAP, and 10 ng/mL FGF-2 (Chemicon) for forty 
days with a medium change twice per week. Controls for osteogenic treatment were cultured in 
growth medium.  Cells were then washed twice with PBS− for 5 minutes each, fixed with 3.7% 
formaldehyde for 15 minutes, and washed twice with PBS− for 5 minutes each. 
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 To stain for calcium deposits, cells were rinsed in distilled water and stained with 2% 
alizarin red S (MP biomedical) by standard procedures (De Bari et al, 2001).  For ICC analysis, 
cells were washed twice with PBS− for 5 minutes each, then incubated with 5 µg/mL of mouse 
monoclonal to osteocalcein (abcam) in PBS-Tween for 30 minutes.  Cells were then washed 
three times with PBS-Tween for 5 minutes each and further incubated with 4 µg/mL of goat anti-
mouse IgG Alexa 488 (Invitrogen) in PBS-Tween for 30 minutes.  Cells were then washed with 
twice with PBS− for 5 minutes each.  All histochemical and ICC incubations were completed at 
room temperature. 
 
In Vitro Adipogenesis 
 For Adipogenic differentiation, a modified technique described by Sabatini et al. was 
used.  Cells were seeded at 0.1 × 106 cells per well into six wells of a 24 well plate and cultured 
to confluence; this was designated as day 0.  Starting at day 1, the cells were stimulated with 
medium containing 90% DMEM L-Gln, 10% FC III, 0.1µM dex, 0.2 mM indomethacin (EMD), 
0.5 mM 3-isobutyl-1-methylxanthine (EMD), and 10 µg/mL human recombinant insulin (EMD) 
for forty days with a medium change twice a week.  Controls for adipogenic treatment were 
cultured in growth medium.     
 For histochemical staining, cells were washed twice with PBS− for 5 minutes each, fixed 
with 3.7% formaldehyde for 15 minutes, washed with distilled water, rinsed in 60% isopropanol 
and covered with 0.3% oil red O (MP biomedical) solution in 60% isopropanol.  After 10 
minutes, cells were rinsed in 60% isopropanol and washed thoroughly in distilled water.  Nuclei 
were counterstained with hematoxylin for one minute and washed thoroughly in distilled water.  
For ICC analysis, cells were washed twice with PBS− for 5 minutes each, fixed with ice-cold 
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methanol for 10 minutes, and washed twice with PBS− for 5 minutes each, then incubated with 8 
µg/mL of rabbit polyclonal to PPAR-gamma (abcam) in PBS-Tween for 30 minutes.  Cells were 
washed three times with PBS-Tween for 5 minutes each and further incubated with 4 µg/mL of 
donkey anti-rabbit IgG Alexa 488 (Invitrogen) in PBS-Tween for 30 minutes.  Cells were 
washed twice with PBS− for 5 minutes each and nuclei were counterstained with 0.5 µg/mL 
Hoechst 33342 for 10 minutes.  All histochemical and ICC incubations were completed at room 
temperature.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 24 
RESULTS 
 
 Bone marrow-derived stem cells (hMSC-BM1), umbilical cord blood-derived stem cells 
(hMSC-SC00125), quiescent (SS-2352) and FGF-2 stimulated (2352) adult human dermal 
fibroblasts were stimulated to differentiate into the three main lineages for forty days under 
appropriate conditions.  Histochemical and immunocytochemistry (ICC) assays were performed 
on the cell cultures to determine the success of specific differentiation protocols.  Table 1 
represents a summary of the histochemical and ICC staining completed for the hMSC-BM1, 
hMSC-SC00125, 2352, and SS-2352 cell cultures. 
 
 
 
 
      
 
 
 
Chondrogenesis  
 Toluidine blue O staining of hMSC-BM1 micromass cultures displayed cartilage-specific 
metachromasia specific for highly sulfated proteoglycans, a biochemical feature of cartilage 
proteoglycans (De Bari et al, 2001).  hMSC-SC00125 and 2352 treated micromass cultures were 
negative.  Untreated controls were also negative (Figure 1).  Immunocytochemical analyses of 
expression of collagen type II a salient marker of chondrocytes on hMSC-BM1, 2352, and 
hMSC-SC00125 micromass cultures were negative (data not shown).  
Adipogenic Treatment Osteogenic 
alizarin red S 
Chondrogenic 
toluidine blue O oil red O PPARγ  
hMSC-BM1 + + +++ +++ 
hMSC-SC00125 − − − ND 
2352 − − ++ ++ 
SS-2352 ND ND ++ ++ 
Table 1:  Summary of histochemical and immunocytochemical (ICC) staining on hMSC-BM1, hMSC-
SC00125, 2352, and SS-2352 cells.  Positive (+) or negative (−) indicate the presence or absence of possible 
positive staining.  Note: ND = not determined 
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Osteogenesis 
 Alizarin red S staining of hMSC-BM1 and hMSC-SC00125 monolayer cultures treated 
with osteogenic differentiation medium revealed possible calcium deposits.  FGF-2 stimulated 
fibroblasts (2352) stained negative for calcium deposit formation.  Untreated controls were also 
negative (Figure 2).  Immunocytochemical analyses of expression of the marker osteocalcein 
from hMSC-BM1, 2352, and hMSC-SC00125 monolayer cultures were negative (data not 
shown).  
 
 
 
      
              hMSC-BM1 
 
 
 
 
 
 
 
 
                          2352 
 
 
 
 
 
 
 
        hMSC-SC00125 
Figure 1:  Chondrogenic differentiation in hMSC-BM1, 2352, and hMSC-SC00125 cells.  Cells were 
cultured in chondrogenic medium (treated) or growth medium (control) for forty days.  Toluidine blue O 
histochemical staining displayed cartilage-specific metachromasia.  Note: Accumulation of lipid vacuoles 
intracellularly in the treated wells (arrows). 
        CONTROL                                  TREATED 
               ↓ 
  ↑  
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Adipogenesis 
 Adipogenic differentiation was demonstrated by the accumulation of lipid vacuoles and 
by the expression of a well-recognized early transcription factor in adipogenesis, peroxisome 
proliferator activator receptor gamma (PPAR-γ) in cultures treated with adipogenic medium.  
Lipid vacuoles were observed as soon as five days for the hMSC-BM1 cells and 12-15 days for 
the 2352 and SS-2352 cells.  The lipid vacuoles increased in size and number and stained 
positive with oil red O.  Oil red O staining of untreated hMSC-BM1 culture showed basal 
  
  
  
     
 
             hMSC-BM1 
 
 
 
 
 
 
 
                       2352 
 
 
 
 
 
 
 
 
      hMSC-SC00125 
 
       CONTROL                                      TREATED 
Figure 2:  Osteogenic differentiation in hMSC-BM1, 2352, and hMSC-SC00125 cells.   Cells were cultured in 
osteogenic medium (treated) or growth medium (control) for forty days.  Possible calcium deposits were 
revealed by histochemical staining with alizarin red S (arrows).   
 
 ↓ 
 ↓ 
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staining in a few of the cells (arrows).  All other untreated controls and hMSC-SC00125 cells 
were negative (Figure 3).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
 
             hMSC-BM1 
 
 
 
 
 
 
     
                        2352 
 
 
 
 
 
 
 
 
                   SS-2352 
 
 
 
 
 
 
 
 
       hMSC-SC00125 
 
Figure 3:  Adipogenic differentiation in hMSC-BM1, hMSC-SC00125, 2352, and SS-2352 cells.  Cells 
were cultured in adipogenic medium (treated) or growth medium (control) for approximately forty days.  Oil 
red O histochemical staining revealed accumulation of lipid droplets within the cells.  Nuclei were 
counterstained with hematoxylin.  Note: The basal staining in a few cells from the control culture from the 
hMSC-BM1 plate (arrows). 
 
 
 
 
 
         CONTROL                                     TREATED 
     ← 
↓ 
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 Immunocytochemical analyses revealed that all treatments except one stained positively 
for expression of the marker PPAR-γ.  hMSC-SC00125 cells were negative (data not shown). 
Untreated controls showed basal staining (Figure 4).  Note the difference in the staining of the 
PPAR-γ expression between the bone marrow-derived stem cells, quiescent and FGF-2 
stimulated dermal fibroblasts. The bone marrow-derived stem cells showed stronger staining for 
PPAR-γ compared to FGF-2 stimulated and quiescent skin-derived fibroblasts that also exhibited 
some peri-nuclear staining for this antigen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
Figure 4:  Adipogenic differentiation in hMSC-BM1, 2352, and SS-2352.  Cells were cultured in adipogenic medium 
(treated) or growth medium (control) for forty days. Adipogenic differentiation were revealed by immunocytochemical 
staining for expression of early transcription factor for adipogenesis, PPAR-γ and viewed under a fluorescent 
microscope.   Note: Basal staining of cells from the control cultures was also observed (arrows). 
     CONTROL                                          PPAR-γ 
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                            2352 
                                      
 
 
 
 
 
              
                      SS-2352 
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DISCUSSION 
 
 In the present study, we characterized the multipotency of umbilical cord blood-derived 
stem cells, quiescent and FGF-2 stimulated adult human dermal fibroblasts compared to bone 
marrow-derived stem cells.  We demonstrated that under the given culture conditions the bone 
marrow-derived stem cells, quiescent, and FGF-2 stimulated adult human dermal fibroblasts can 
be induced to differentiate in vitro toward adipogenesis.  However, none of the treatments were 
successfully induced to differentiate in vitro towards osteogenesis or chondrogenesis even 
though the bone marrow-derived stem cells had some alizarin red and toluidine blue staining. 
 ICC assays showed no expression of salient markers, osteocalcein or collagen type II 
even though histochemical analysis revealed possible positive staining in the bone marrow-
derived stem cell micromass cultures.  Studies have shown that the use of serum can cause cells 
to spontaneously differentiate into an undesired cell lineage.  Expression of early transcription 
factor, PPAR-γ, inhibits in vitro differentiation towards osteogenesis and chondrogenesis 
(Gregory et al, 2005).  Both the chondrogenic (Figure 1) and osteogenic (data not shown) 
treatments had showed evidence of lipid pocket formations intracellularly thereby inhibiting 
formation of calcium deposits, and proteoglycans. Untreated controls also showed basal 
expression of PPAR-γ (Figure 4).  The glucocorticoid, dexamethasone has been shown necessary 
for nodule formation and mineralization despite the fact that it has shown both stimulatory and 
inhibitory effects on osteogenic differentiation depending on concentration, duration of exposure 
stage of differentiation, and species of responding cells (Jaiswal et al, 1997).  Dexamethasone 
has also been reported to suppress the induction of collagen type II expression for chondrogenic 
differentiation (Awad et al, 2001).   
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 The bone marrow-derived stem cells, quiescent, and FGF-2 stimulated adult human 
dermal fibroblasts were successful in differentiating into the adipogenic lineage.  Lipid pocket 
formations were observed microscopically and stained positive with oil red O.  ICC staining for 
expression of early transcription factor PPAR-γ revealed further evidence of adipogenic 
differentiation (Sabatini et al, 2005).  The bone marrow-derived stem cells showed stronger 
staining for PPAR-γ compared to FGF-2 stimulated and quiescent skin-derived fibroblasts which 
also exhibited some peri-nuclear staining for this antigen.  
 
Suggestions for Future Experiments 
 One of the major challenges that needs to be overcome is the ability of each treatment to 
adhere to the tissue culture vessels throughout the duration of the experiment.  For example, the 
quiescent skin-derived fibroblasts (SS-2352) were unsuccessful in adhering to the 24-well 
culture plate following induction with osteogenic or chondrogenic media.  Results were unable to 
be generated for these treatments due to the lack of cells.  Studies have shown that tissue 
engineers are fabricating matrix scaffolds that are often based on collagen, mineralized calcium, 
or fibrin, all of which are naturally occurring constituents of cartilage ECM.  Other naturally 
occurring materials such as gelatin have also been used (Heng et al, 2004).  Coating the 24-well 
culture plates with gelatin or collagen may provide a physiological environment to promote 
adherence of the cell treatments. 
 Extracellular matrix has been implicated in playing an important physiological role by 
influencing the microenvironment of chondrocytes embedded within it.  In the present study, 
micromass cultures were utilized in attempts to replicate the appropriate microenvironment but 
failed to promote chondrogenic differentiation.  Studies have shown that the use of agarose gel or 
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thermo-reversible hydrogel constructs permits the cells to exist in a round configuration which 
has shown to favor the maintenance of the cartilage phenotype and promote chondrogenic 
differentiation (Na et al, 2006).  
 It is also important to consider investigating other cytokines and growth factors that may 
lead to chondrogenic and osteogenic differentiation.  FGF-2 has also shown to play an important 
role in chondrogenesis.  The effect of FGF-2 is primarily through MAPK signaling which lead to 
the increased expression of the transcription factor Sox-9, a major regulator of chondrogenesis 
(Heng et al, 2004).  The role of the cytokine bone morphogenic protein 2 (BMP-2) in addition to 
FGF-2 has been recognized as a potent bone inducer that elicits new bone formation.  The 
exposure of BMP-2 to dex-treated MSCs was reported to slightly enhance osteogenic 
differentiation (Maegawa et al, 2007).  Commercially available differentiation medium (e.g. 
Lonza’s hMSC Chondrogenic Differentiation BulletKit) is also available but formulations are 
proprietary masking customization and detailed optimization of important constituents difficult.  
 
Conclusions 
 MSCs were indentified over three decades ago and exhibit properties such as 
multipotency, expansion in vitro, and hypoimmunogenecity that makes them ideal candidates for 
tissue engineering applications.  However, obtaining large populations has been a major hurdle 
and not much progress has been made in developing defined cultured medium for expansion.  
The ability to direct the cells into a specific lineage, achieving complete terminal differentiation, 
and maintenance of the differentiated state are essential prerequisites for tissue engineering 
applications. 
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